BERTINI, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 8.951
AS - Asia 4.105
EU - Europa 3.674
SA - Sud America 563
AF - Africa 140
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.444
Nazione #
US - Stati Uniti d'America 8.706
SG - Singapore 1.376
IT - Italia 1.352
CN - Cina 1.203
HK - Hong Kong 683
DE - Germania 574
BR - Brasile 490
SE - Svezia 461
BG - Bulgaria 324
TR - Turchia 260
GB - Regno Unito 200
CA - Canada 197
VN - Vietnam 196
RU - Federazione Russa 155
FI - Finlandia 144
FR - Francia 122
IN - India 113
AT - Austria 98
UA - Ucraina 80
NG - Nigeria 61
KR - Corea 59
JP - Giappone 56
AR - Argentina 26
NL - Olanda 25
BE - Belgio 24
CH - Svizzera 21
MX - Messico 20
MA - Marocco 19
CI - Costa d'Avorio 18
IQ - Iraq 18
PK - Pakistan 18
BD - Bangladesh 17
ID - Indonesia 17
SA - Arabia Saudita 15
CZ - Repubblica Ceca 14
GR - Grecia 14
IL - Israele 14
PL - Polonia 14
ZA - Sudafrica 13
ES - Italia 12
EC - Ecuador 11
UZ - Uzbekistan 11
AU - Australia 8
AZ - Azerbaigian 8
RO - Romania 7
RS - Serbia 7
VE - Venezuela 7
CO - Colombia 6
EG - Egitto 6
PE - Perù 6
TN - Tunisia 6
UY - Uruguay 6
PA - Panama 5
PY - Paraguay 5
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
IE - Irlanda 4
IR - Iran 4
LT - Lituania 4
SN - Senegal 4
TH - Thailandia 4
DM - Dominica 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BJ - Benin 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
LK - Sri Lanka 2
LU - Lussemburgo 2
OM - Oman 2
PH - Filippine 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
Totale 17.433
Città #
Woodbridge 1.037
Ashburn 999
Ann Arbor 766
Singapore 745
Hong Kong 678
Fairfield 656
Chandler 648
Houston 562
Santa Clara 484
Serra 461
Dallas 373
Sofia 324
Shanghai 280
Cambridge 274
Wilmington 256
Beijing 254
Seattle 232
New York 196
Ottawa 170
Izmir 167
Boardman 147
Princeton 145
Lawrence 122
Milan 112
Medford 107
Los Angeles 100
Nanjing 98
Pisa 92
Jacksonville 87
Hefei 84
Vienna 83
Munich 75
Dong Ket 74
Istanbul 67
Marseille 64
Redondo Beach 63
Lagos 61
Des Moines 59
Seoul 58
London 56
Nanchang 55
Dearborn 53
Buffalo 51
Florence 49
Redwood City 46
São Paulo 42
Boulder 36
San Diego 36
Tokyo 36
Columbus 33
The Dalles 33
Rome 29
Turku 26
Pune 24
Ogden 23
Brussels 22
Fuzhou 22
Nürnberg 22
Pistoia 22
Shenyang 22
Ho Chi Minh City 21
Council Bluffs 20
Kunming 20
Frankfurt am Main 18
Guangzhou 18
Norwalk 18
Abidjan 17
Nuremberg 17
San Francisco 17
Bern 16
Livorno 15
Belo Horizonte 14
Hangzhou 14
Hanoi 14
Hyderabad 14
Mumbai 14
Jakarta 13
Jiaxing 13
Warsaw 13
Casablanca 12
Chicago 12
Jüchen 12
Lucca 12
Tianjin 12
Atlanta 11
Brooklyn 11
Hebei 11
Washington 11
Brasília 10
Brno 10
Carrara 10
Düsseldorf 10
Falls Church 10
Helsinki 10
Jinan 10
Orange 10
Phoenix 10
San Jose 10
Zola Predosa 10
Changsha 9
Totale 12.527
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 339
Application of An Improved HPLC-FL Method to Screen Serine Palmitoyl Transferase Inhibitors 230
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 227
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 216
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system 214
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 203
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor 200
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 198
Identification of the first synthetic allosteric modulator of the CB2receptors and evidence of its efficacy for neuropathic pain relief 196
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 195
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 192
Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase 192
Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials 192
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 190
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands 189
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 188
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 187
Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor 186
Efficient application of monolithic silica column to determination of illicit heroin street sample by HPLC 185
CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides 184
Composition of health-promoting phenolic compounds in two extra-virgin olive oils and diversity of associated yeasts 182
4-[6-(dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptor 182
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors 181
Antiproliferative oxime derivatives that inhibit glucose transporter 1 (GLUT1) in cancer cells 181
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery 181
Estrogen receptor ligands: a patent review update 178
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors 178
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system 178
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 177
Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model 174
Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands 174
7-Nitrobenzofurazan (NBD)-Derivatives Of 5'-N-Ethylcarboxamidoadenosine (NECA) As New Fluorescent Probes For Human A3 Adenosine Receptors 173
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes 170
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 168
Selective activators of estrogen receptor beta based on the aldoxime and ketoxime scaffolds 167
Olive Mill Wastewater as Source of Polyphenols with Nutraceutical Properties 165
Diaryl-substituted salicyl- and anthranyl-ketoximes as potential estrogen receptor ligands 165
Biphenyl-Derivatives Possessing Tertiary Amino Groups as ß-Secretase (BACE1) Inhibitors 163
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells 163
Synthesis of a Resveratrol Analogue with High Ceramide-Mediated Proapoptotic Activity on Human Breast Cancer Cells 160
Variously substituted (phosphonoacetamido)oxy analogues of geranylgeranyl diphosphate (GGdP) as GGdP-transferase (GGTase) inhibitors and antiproliferative agents 159
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 158
Synthesis of aniline-type analogues of farnesyl diphosphate and their biological assays for prenyl protein transferase inhibitory activity 156
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 154
Metabolically labile cannabinoid esters: A ‘soft drug’ approach for the development of cannabinoid-based therapeutic drugs 149
BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides 148
Novel Estrogen Receptor Ligands Based on an Anthranylaldoxime Structure: Role of the Phenol-Type Pseudocycle in the Binding Process 145
Antiproliferative activity and cell cycle analysis of 2-(3,5-dihydroxyphenyl)-6-hydroxybenzothiazole on MCF-7 breast and HCT-15 colon cancer cell lines. 145
Carbazole-containing arylcarboxamides as BACE1 inhibitors 143
Synthesis and antiviral properties of novel analogues of monophosphate and diphosphate bioactive forms of acyclovir 143
Synthesis, Antifungal Activity, and Molecular Modeling Studies of New Inverted Oxime Ethers of Oxiconazole 142
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 142
200 Esercizi Risolti di Chimica Generale ed Inorganica 141
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells 141
Aminobenzothiazoles as beta-Selective Estrogen Receptor Ligands 140
Development of Methods for Recovering Endotoxins from Surfaces and from Air in Production Environment of Injectable Drugs 139
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 138
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 138
18FLUORINE-LABELED NITROGEN HETEROCYCLIC DERIVATIVES AS NEW CANDIDATE FOR CANNABINOID CB2 RECEPTOR PET IMAGING 137
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors 132
A theoretical study to investigate D2DAR/D4DAR selectivity: Receptor modeling and molecular docking of dopaminergic ligands 132
Multi-targeted ChEI-copper chelating molecules as neuroprotective agents 132
alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors 130
Aminobenzothiazoles as inhibitors of tau-fibril formation in Alzheimer's and other neurodegenerative diseases 130
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 130
SERINE PALMITOYLTRANSFERASE INHIBITION: A VIRTUAL SCREENING HYPOTHESIS 128
Aromatic aldoximes as Estrogen Receptor Beta–Selective Ligands 128
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation 127
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis 126
Stable propylphosphonic acid analogues of geranylgeranyl diphosphate possessing inhibitory activity on geranylgeranyl protein transferase 125
Monoaryl-substituted Salicylaldoximes as Ligands for Estrogen Receptor Beta 125
Radiosensitizing potential of small organic molecules toward hypoxic tumor cells in the radiotherapy 123
Salicylaldoxime moiety as a phenolic “A-ring” substitute in estrogen receptor ligands 122
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 122
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases 122
Stable analogues of geranylgeranyl diphosphate endowed of improved geranylgeranyl vs. farnesyl protein transferase inhibitory selectivity 121
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 119
Salicylaldoxime Moiety as a Phenolic "A-Ring" Substitute in Estrogen Receptor Ligands 118
Stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side-chain as inhibitors of prenyl protein transferases 118
Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold 116
Purification, Enzymatic Characterization and Inhibition of the Z-Farnesyl Diphosphate Synthase from Mycobacterium tuberculosis 115
Synthetic hydroxylated aryl-naphthalene derivatives as resveratrol rigid analogues showing ceramide-mediated antiproliferative and pro-apoptotic properties 114
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 113
Predictions of binding of estrogen receptor agonists by a combination of molecular dynamics and continuum solvent models 113
Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-Substituted 3,4-Diarylsalicylaldoximes on estrogen receptors a and ß 111
Cannabinoid-Based Medicines and Multiple Sclerosis 111
Insights into the Antioxidant/Antiradical Effects and In Vitro Intestinal Permeation of Oleocanthal and Its Metabolites Tyrosol and Oleocanthalic Acid 107
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor 107
Synthesis and biological evaluation of new compounds as cannabinoid receptor type 1 allosteric modulators 107
Structural Evolutions of Salicylaldoximes as Selective Agonists for Estrogen Receptor Beta 106
Assessment of a HPLC assay for monoacylglycerol lipase activity 106
Content Variations in Oleocanthalic Acid and Other Phenolic Compounds in Extra-Virgin Olive Oil during Storage 106
Enhanced Nutraceutical Properties of Extra Virgin Olive Oil Extract by Olive Leaf Enrichment 105
N-Metilantranilaldossime aril-sostituite come ligandi estrogenici 105
Alzheimer Diseases: Design and synthesis of new BACE inhibitors 102
Salicylaldoxime-Based Ligands for Estrogen Receptor Beta Showing Potent Agonist Properties 102
Synthesis and Biology of NBD-Derivatives of Neca as New Fluorescent Probes for Adenosine Receptors 102
Alternatives to phenol-based estrogen receptor ligands 101
Design, synthesis and biological evaluation of 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as soft-drugs 99
Halogen-selective cross-coupling reactions in the synthesis of ligands for the estrogen receptors 96
Totale 15.075
Categoria #
all - tutte 48.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021689 0 0 0 0 0 56 79 122 113 92 59 168
2021/20221.478 30 184 53 52 225 185 61 76 31 51 77 453
2022/20231.831 210 276 145 158 246 241 11 134 267 12 85 46
2023/20241.042 105 104 106 43 147 203 83 37 17 19 41 137
2024/20253.927 20 164 87 256 401 404 299 197 436 515 421 727
2025/20262.545 307 530 471 340 459 438 0 0 0 0 0 0
Totale 17.789